Top

Response to Questions in regard to HHS-NIH-NCI-SN-MOSB-75N91020R00062-27

Active

HHS-NIH-NCI-SN-MOSB-75N91020R00062-29Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The National Cancer Institute (NCI) issued a Special Notice to address questions related to its ongoing acquisition process for the Federally Funded Research and Development Center (FFRDC) contract at the Frederick National Laboratory for Cancer Research (FNLCR). This notice clarifies that the Government intends to award the contract around December 18, 2024, with negotiations planned to begin after internal document reviews are completed. Additionally, it was noted that the previously proposed three-year extension of the incumbent FNLCR contract has been reduced to a 12-month extension. The Notice emphasizes that no modifications have yet been made to the current Statement of Work (SOW), and any relevant updates or documents will be shared publicly when available. The announcement also underscores that all procurement-related information is disseminated equally to all interested parties through official Special Notices posted on SAM.gov, which serves as the authoritative source. Interested parties are encouraged to monitor both SAM.gov and the FNLCR Acquisition Portal for the latest updates. For further inquiries, the NCI has designated a dedicated acquisition team reachable via email to provide additional guidance. This notice is strictly informational and not a solicitation for proposals or responses.

General Info

NCI plans December 2024 FFRDC contract award with 12-month extension; updates via SAM.gov.

Agency

Department Of Health And Human Services → NIH Nci

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedFeb 28

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → NIH Nci

ContactsNo contacts available

OfficeBethesda, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → NIH Nci

Office AddressBethesda, MD, 20892, USA

ContactsNo contact information available

Full Description

Notice Type: Special Notice Notice Number: HHS-NIH-NCI-SN-MOSB-75N91020R00062-29 Synopsis: Respond to questions received in regard to Special Notice HHS-NIH-NCI-SN-MOSB-75N91020R00062-27 for the National Cancer Institute's (NCI) Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR) Date: February 28, 2024 Note: THIS IS A SPECIAL NOTICE, NOT A REQUEST FOR PROPOSAL, PROPOSAL ABSTRACTS OR QUOTATIONS. This notice is pursuant to FAR_5.201(b)(1)(ii). PURPOSE: The purpose of this Special Notice is to answer questions submitted in response HHS-NIH-NCI-SN-MOSB-75N91020R00062-27: Question: Please provide in as much detail as possible on the current acquisition schedule, including your current status (i.e. peer review complete?, proposal evaluations complete?, competitive range established?, etc.) and your plans and timing for discussions/negotiations, RFP amendments, potential final proposal revisions, and award? Response: As provided in the public announcement released January 31, 2024, the NCI is planning to award the contract on/or around December 18, 2024. It is the Government's intention to open negotiations after review of internal documents is completed. Question: How does the 3-year extension to the incumbent FNLCR contract align with the latest FNLCR acquisition schedule? Response: The NCI released an amended special (HHS-NIH-NCI-FFRDC-MOSB-0002) notice indicating that the proposed extension has been reduced from 3 years to 12 months. Question: To ensure we understand the current contract, which is the starting point for the transition, we request that NCI provide a copy of the contract modification(s) effecting the option terms identified in notice HHS-NIH-NCI0FFRDC-MOSB-0001 and any related sole source Justification and Approval for extending the current FNLCR contract. Response: No modifications have been executed to the SOW as of this date. Any information that is pertinent to interested parties will be released through public notice when we are able to do so. Question: Is there anything that you need to share with us to ensure we have the same information about the procurement as the incumbent contractor? Response: Any information related to the re-competition is provided to all parties through the Special Notices released in SAM.Gov. ADDITIONAL INFORMATION: Additional information concerning the competitive process for the contract will be announced on https://sam.gov/ as well as at the FNLCR Acquisition Portal: https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/. The information posted to SAM takes precedence over information provided elsewhere and serves as the Government's official government-wide point of entry (GPE). If you have questions, please email the FNLCR Acquisition Team at: FNLCR_ACQinfo@nih.gov